Stable in a Genome of Instability: An Interview with Evan Eichler by Gitschier, Jane
Interview
Stable in a Genome of Instability: An Interview with
Evan Eichler
Jane Gitschier*
Departments of Medicine and Pediatrics, Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America
We like to think that our genome is rock-
solid, that it is dependable, there for us
when we need it. The truth is far from
that. By fits and starts, our species’
collective genome is undulating, reshaping
itself with eruptions of genomic lava and
clashes of sequence tectonics, at once both
marvelous and unsettling. We are unaware
of this tumult within us until we are
confronted with disease in ourselves, our
friends, or our family.
Evan Eichler is a man obsessed with this
process, and to speak with him is a study in
contrasts (Image 1). An unassuming Ca-
nadian, Eichler is a student of genomic
architecture, the arrangement of sequenc-
es in our genome, and their evolution.
Eichler grew up on a farm in Manitoba,
married his college sweetheart, and now
lives together with her and their four
children in the mountains east of Seattle.
As we walked up the hill to my office
during his recent visit to UCSF, he talked
about being an early riser, taking his son to
band practice before school, and then
driving the 30 miles to work in his Toyota.
Eichler is a man bristling with excitement
for his discoveries, but holding it in check
by a tradition of modesty. He has
consistently followed his own path, chosen
career opportunities that were dictated not
by politics or peer pressure but rather by
what feels like a good fit for him.
Our conversation ranged from tiny
triplet repeats to large and complicated
duplications, some of which harbor genes
of uniquely human import, and the
process of their discoveries.
Gitschier: Your thesis advisor, David
Nelson, told me that when you came to
Baylor [College of Medicine] as a first-
year graduate student, you already knew
you wanted to study genome evolution.
Eichler: That’s true.
Gitschier: How did you know that?
Eichler: I was at the University of
Saskatchewan [as an undergraduate] and
I was in Biology. They didn’t have a
genetics program, but I knew even before I
went there that I wanted to do genetics.
Gitschier: And how did you know that?
Eichler: It started out in grade 9 or 10.
My family grew up on a farm, and we
started to raise angora rabbits for the
purpose of their wool. My mother was one
of those folks for whom everything had to
be done naturally. So we had to pull the
wool, we couldn’t clip the wool. (It’s
OK—the rabbits are fine with it!) She
spun her own wool. And she didn’t believe
in dying the wool.
She said to me, ‘‘I want different colors
of wool, but I don’t want to use dyes.’’ And
in grade 9, I learned how to use the
Punnett Square to keep track of the five
gene coat color system in rabbits. I got a
little textbook, and I started breeding these
rabbits. I joke that that was the only time I
ever did classical genetics!
I did those experiments, and within a
couple of generations, I got all the colors
that she wanted. I could breed them true.
My mother was so impressed! It’s amazing
what you can do!
At that point, I decided that genetics
was what I wanted to do. And by the high
school years, after reading stuff, I realized
I wanted to do human genetics.
So my father looked into a number of
different universities to check out the
genetics programs, but I ended up settling
on a place where there was no genetics,
because it was close to home.
I wanted to take more molecular
courses, but I ended up taking more
ecology, evolution, and anthropology,
because it was part of the curriculum.
They [the faculty there] didn’t believe in
what they called ‘‘reductionist’’ biology.
Gitschier: But that served you so well in
the long run!
Eichler: This is, I think, where my
interest in evolution [was] sparked. And
when I finished my Bachelor’s degree,
one of my professors said, ‘‘If you want to
do human genetics, you have to get an
MD’’.
So I thought about that, and I took a
year off. I got a fellowship to study in
Munich, at a veterinary research institute.
And there I got real exposure to research,
and that’s where I applied to different
[graduate] schools—Sick Children’s in
Toronto, Hopkins, Yale, and Baylor.
And got invitations from those schools
but eventually went to Baylor. I thought
the research there was comparable to that
at the big names, and I thought the people
like David and Phil Soriano, who had
interviewed me on the phone, had this
folksy feel—really down to earth, but very
high energy and, obviously, top quality.
My uncles gave me a hard time: ‘‘You
had a chance to go to an Ivy League
school and you’re going to Texas!’’ But at
that time, Tom Caskey had such a great
enterprise there. He had such great taste
and recruited such impressive faculty. I
was so happy there.
Gitschier: And you went, without even
looking at it?
Eichler: I hadn’t seen the city, and if I
had, maybe I would have changed my
mind! I went there. I wasn’t married yet,
so I had to fly back [to Canada], marry my
wife in the middle of midterms and bring
her down, and she said ‘‘I cannot believe
you have moved me from Canada to here.’’
She hated it for the first 6 months, but
eventually she grew to like the city and the
Medical Center.
I was extremely lucky to find David
Nelson as my mentor. There was an
instantaneous click—a chemistry. He gave
me complete freedom, but he was an
academic rock. When I came up with
ideas, he would quickly find where the
flaws were and then allow me to go on and
pursue them. I was one of those strange
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exams because I couldn’t decide what I
wanted to do. My committee told me to
focus, but David said, ‘‘Eh, do what you
want,’’ shrugging his shoulders.
Gitschier: I can just hear him saying
that!
Eichler: And I loved this whole Fragile X
thing—the idea of a mutation being
dynamic, and a premutation state. The
anticipation phenomenon [that disease risk
increases in subsequent generations, now
knowntobeduetotripletrepeatexpansion]
had been rejected by a lot of mainstream
geneticists ten years before—they thought it
was just ascertainment bias. And then to
have it all resolved by Ying-Hui Fu and
David, to be there at that moment when
those Cell papers were coming out! When I
came to that lab, from early on, I was
interested in studying that process from an
evolutionary perspective.
When I think about duplications, I think
about them exactly along those same
lines—as a dynamic mutational process.
Instead of slippage of triplet repeats, it is
non-allelic homologous recombination.
These regions, unlike most of the genome,
break all the rules. They can have very
accelerated rates, and then pause, if there
is selection, either positive or negative.
They beat to their own tempo.
I started working on the mechanism of
the instability. Why do triplet repeats
expand at all? From Ying-Hui’s sequencing
work, we knew there were AGG interrup-
tions in the CGG repeats. So working with
David and Steve Warren, we came up with
a model that a loss of AGG interruptions
would predispose alleles to change. We
showed that alleles that lacked the AGG
interruptions moved toward premutation
and disease state much more quickly within
the human population. Some populations,
such as Tunisian Jews, had a disproportion-
ately large number of uninterrupted alleles,
and in these same populations, Fragile X
syndrome was much higher. So what
mattered [in promoting instability] was a
pure tract of CGG rather than the total
number of repeats.
Gitschier: Other primates don’t have
fragile sites, do they?
Eichler: Not that we ever have observed,
and they also have many more interrup-
tions in the CGG sequences, and different
types of interruptions in different species.
And you never see the amplification and
the fragile site.
All microsatellite lengths in other spe-
cies are shorter on average than in
humans. Even the polyglutamine-coding
tracts. It’s almost as if the human species
has been sloppy to allow these types of
track lengths to increase, unless they have
some kind of benefit.
At the end of my PhD,I got a sideproject
going—to map the Emery muscular dys-
trophy gene. So I started mapping cosmid
clones in the Xq28 region, and, lo and
behold, as I was walking across that region I
got some unusual results—cosmids that
shouldhavecomefromtheX-chromosome,
but hybridized by FISH to multiple loca-
tions. One clone had the creatine transport-
er locus, and it hybridized clearly to both
Xq28 and 16p11.2. And another one—the
adrenal leukodystrophy locus—it hybrid-
ized to four locations in addition to Xq28.
That’s when I started the idea of looking
at duplications and copy number varia-
tion, in 1996, 1997.
Gitschier: At the time, were you really
thinking about copy number variation
within species, or just about the evolution
of segmental duplications?
Eichler: At that time I would have been
thinking about segmental duplications and
copy number variations between species.
But it was shortly thereafter—1997,
1998—that copy number variations within
a species became apparent.
There were pericentromeric duplica-
tions, proximal to the Pradi-Willi region
on 15q, published by Marc Lalande, and
another paper by John Barber reporting
larger 16p11 copy-number variations.
Both of these papers showed copy number
variation in large segmental duplications
in normal individuals, and most of this
variation was thought to be evolutionarily
quite young, less than 10,000 years. Barb
Trask had shown in 1998 that the
subtelomeric regions had dramatic struc-
tural variation between species and within
humans. And all of this was way preceding
any of the hype in 2004 about copy
number variation.
Gitschier: I know what you mean.
Suddenly there appeared an acronym
‘‘CNV’’ [copy number variation] for
something that had been known about
for quite a while.
Eichler: One of the problems with
genomics, in particular, is that the collec-
tive memory seems to be about five
minutes to twelve [o’clock]. It’s where
people are at the last three or four minutes
before the bell tolls that seems to matter
and they forget everything that went
before. It’s a little bit frustrating, but I
imagine everybody feels this at some point.
It’s not that these ideas appear out of
nowhere. It’s not a vacuum and suddenly
a light goes on one day! They’re built
upon many studies over many years.
So between 1996 and 1998, we were
already thinking about copy number vari-
ation, but we wanted first to understand the
organization [of duplications] in humans,
and then understand the difference between
humans and other primates, and then focus
again on humans, distinguishing normal
and disease-causing variation.
Gitschier: You must have great compu-
tational skills to do this kind of work.
Eichler: I’m not a programmer, and I
never took a single class in it. But David
was a big fan of UNIX. I never was afraid
of moving big data sets around.
What happened to me was that we had
done these anecdotal studies looking at dupli-
cations, repeats, variations between species,
and then a couple of things happened.
First, I took my faculty position at Case
Western Reserve University. Hunt [Will-
ard] and Aravinda [Chakravarti] recruited
me. David and I had been working on a
paper with Aravinda on Fragile X haplo-
type analysis. He heard I was job hunting
and said, ‘‘Why don’t you come and look
over here?’’ I thought, ‘‘That is a great
place!’’ Hunt had the chromosome struc-
ture part, Aravinda was doing the human
genetics disease angle, Rob Nicholls doing
the Pradi-Willi/Angelman work. It felt like
a natural fit with that whole faculty. And
Cleveland is great! It was cheap. The
people there seemed so down to earth. It
was just a perfect fit for me and my
research. So I moved there in 1997.
Gitschier: So now, let’s talk about how
you moved to the whole genome problem,
which I assume is the second ‘‘thing’’ that
happened.
Eichler: Yes, moving from studying
individuals’ genes, duplications, and vari-
ations between species, to genome-wide.
This was right at the time when the
genome project was basically hoping to
finish up in the next few years.
There was a culture shift, in 1998, as
follows: The whole [publicly sponsored]
genome project had been done, up to that
point, methodically, slowly, BAC by BAC,
fosmid by fosmid, cosmid by cosmid,
people assigned chromosomes and doing
their regions, reporting their results at
chromosome-specific workshops. And at
that point, there was a shift, essentially:
[Craig] Venter. Venter saying he was
going to do it faster and better and sell it
as a marketable product.
So [as part of this race] I was brought to
NIH—first time I had ever been there. I
knew that they [segmental duplications]
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they would be important. We had done
some basic analysis to see how good this
working draft sequence would be as
opposed to finished sequence.
I remember saying that a working draft
[as opposed to a careful orderly descrip-
tion] would mess up duplications com-
pletely, and that we wouldn’t resolve them
well and it would be a disaster for my
research, blah blah.
But I could tell right then that it didn’t
matter. They were going to sequence lots
of clones, with sequences deposited into
GenBank in the next 13–15 months. MIT
at that point picked up a lot of the
sequencing capacity, and Wash U [Wa-
shington University] was committed to
finished, high-quality sequencing, most in
ordered maps, but not all of them were.
So after that, I got a call from Eric
Lander. He said, ‘‘Evan, we’re going to
have all these assemblies of the human
genome soon, we’d sure like it if you were
willing to do a genome-wide analysis [to
help determine regions of duplication].
Have you ever done a genome-wide
analysis?’’
And I said, ‘‘No.’’
He said, ‘‘Well, can you do it, and can
you do it in 4–5 weeks?’’ This was around
2000.
I lied. I said, ‘‘We can do this.’’
I knew we could do it, but I didn’t know
we could do it that quickly! And so we
went ahead. The sequence came in. We
had to come up with a pipeline to analyze
duplications within the assembly. I had an
awesome student, Jeff Bailey, who was
better at computation than he was at the
bench. So we sat down and drafted what
we would need—how we would do it:
remove the repeats, line up the sequences,
genome by genome, we’d clip—there was
a heuristic involved.
And then we had to execute it, but we
didn’t have enough computers. There was
no cluster or super-computer that we had
access to.
So I walked over to Hunt’s office and
said, ‘‘Hunt, I have an opportunity and I
need some machines. And I have a guy
who is actually capable of re-writing the
operating system and putting Linux on all
these.’’ So he said, ‘‘OK here’s $13,000,
see what you can do.’’
Gitschier: That’s not very much.
Eichler: No! But we went out and
literally bought off-the-shelf from Com-
puter City a whole bunch of machines—I
think they were Dells—and we strung
them up on my lab bench—there were 15
of them. I have a picture of it somewhere.
And Jeff wrote some script that would
distribute the load across the machines so
we could parallelize the operation.
It was the middle of summer in Cleve-
land. And things would go for a week and
crash. And the process was such that you’d
have to start all over again. Two weeks
in—crash.
Gitschier: Power outages?
Eichler: No—heat. The rooms weren’t
air conditioned enough to deal with the heat
that was generated from 15 computers
strung together, side-by-side. We had a
little maelstrom of heat. So the critical
component for this first cluster that we
built was a Kmart fan—actually three of
them—that we stuck in the back and blew
the heat away from the back of the chassis
of the computers, and it finally ran to the
end. We ended up a little bit late, two
weeks late I think, but we did our first
genome-wide analysis.
And it was really disappointing. We
realized that the first assemblies had
screwed up big time—something like
20% of the genome was in these blocks
of duplication, and 90% were false posi-
tives. We were bummed out because we
had put all this energy into a duplication
map. We had all these ideas for evolution
and disease, and we realized that we didn’t
have it yet!
So we reported this back, and they were
like—OK, we’ve got to fix this. So we gave
all the coordinates to [David] Haussler
[developer of the UCSC genome brows-
er]. And additional assemblies went on to
be more rigorous.
But to us, it wasn’t what we wanted.
Which were the false positives, and which
were the real duplications?
So what we did—and here is where we
got into a little bit of trouble—I knew
Venter was doing his genome assembly a
different way, and I knew that his assembly
method would miss the duplications com-
pletely, because they couldn’t actually assem-
ble within a duplicated region. There would
be ‘‘mate-pair’’ violations [mismatches of
two shot-gun end-sequences], and they
would just throw out the discrepant reads.
So we came up with this idea, which is
fairly simplistic. We knew that the best
part of the public [genome sequencing
effort] was that they had individual
haplotype BACs—150,000 base pairs in
individual clones—that were good for
orderly assembly. And, we knew that the
best part of Craig’s was this whole genome
shot-gun approach. So if we could take the
raw data from both projects and merge
them—we’ll use the depth of coverage
[from Craig’s shot-gun sequences] as a
dipstick for duplication, and we’ll take
every BAC [from the public genome
project]—all 36,000 of them—and we’ll
align all of Craig’s reads against them.
Wherever we see excess depth of coverage
and wherever we see excess divergence
will indicate a potential duplication.
So we tested it, and we had a 95% hit
rate on our duplications. We could detect
duplications that were big. By 2002, before
any [final genome] assembly came out, we
had a duplication map, and that was
published [in Science] as a map for future
studies.
And that’s where I got into problems,
because I was analyzing both public and
private human genomes prior to either
being published.
Gitschier: So you had bought into the
Celera database?
Eichler: I didn’t. I collaborated—I col-
laborated with the public and I collabo-
rated with Venter at the same time.
Gitschier: Were there others who did
that, too?
Eichler: I don’t think so, because I
remember getting phone calls warning
me to be careful!
I was interested only in the scientific
question, not the politics. And I explained
that to a number of people including
Francis [Collins] and Eric [Lander], and
Mark Adams at Celera, with whom I had
an established collaboration. I had to keep
a wall of China up between the two
sources. People eventually understood that
I wasn’t contaminating the well, on either
side.
There were two things working in my
favor—most of all I was naı ¨ve, and I just
didn’t understand a lot of things that had
gone on with Congress, and things that
had gone on trying to stifle one project
versus the other. The second thing going
for me was that I was blinded by getting
the duplications sorted out. This would be
the greatest thing since sliced bread in my
life.
Gitschier: And it was!
Eichler: It was great, and fun. For us,
that was a watershed moment. We used
that information to predict regions of
rapid evolutionary turnover as well as
regions that we believed were disease
hotspots, like the autism locus at
16p11.2. And we decided to systematically
go in and look for structural variation in
these regions.
Gitschier: Tell me more about the
duplications.
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whole evolutionary history of the duplica-
tions themselves, what you notice is a
couple of things. One is that humans have
too many interspersed duplications com-
pared to other mammals.
Point number two: the duplication
architecture is very complex, suggesting
that there has been a series of events
creating almost every duplication block, of
which there are about 400 in the human
genome. Most of these have been created
over a period of 10–15 million years,
where it seems that most of the activity
was around the time of the common
ancestor to human and chimp and gorilla.
And then here’s the kicker: if you recon-
struct the entire history of these, they
provide a framework. Because duplica-
tions swap material between them, they
share evolutionary history. You can build
a tree of relationships of the segmental
duplications.
What you see is that most of the
expansions have occurred on about half a
dozen human chromosomes, and most of
these expansions lead to these architectures,
such as on Chromosomes 16 and 17, where
you now have big blocks of duplication
flanking a region and sensitizing it to
microdeletion and microduplication.
So, you ask yourself, ‘‘Why these big
blocks?’’
Here’s what I think, although we
haven’t definitively proven it yet. If you
look at the centers of these big blocks of
duplications—what we call the cores—
these tend to carry rapidly evolving genes
embedded within them.
So we’re coming to a new and what I
think is an important paradigm here:
Architecture that is predisposing to micro-
duplication and microdeletion is there at
the benefit of having these newly minted
genes propagating and expanding across
the human genome.
There are now half a dozen gene
families that have been published—some
by us, some by others—which show these
signatures, and most of the duplication
architecture seems to be almost a genetic
hitchhiker—these cores that have landed
in new areas, picked up flanking material
and duplicated again to other sites.
I would have to think that solving this
riddle of what the function of those genes
are would be tremendous. The genes that
are in there tend to mark the oldest and
the deepest part of the duplication block.
The block itself is a mosaic of different
pieces. There are bits of pieces of genes,
some are transcribed, some are not, most
are neutrally evolving. But the cores carry
genes that show strong signatures of
positive selection. These are genes that
are smack in the middle of hundreds of kb
[kilobases] of complex duplication territo-
ry, where Affymetrix, Agilent, and the
SNP people have feared to tread! This is
the ‘‘un-HapMap-able’’ region of the
human genome. And if there were any
association with any disease, people would
have missed it because there is no type of
genotyping technology to actually assay.
And here’s the rub—these genes are not
only embedded in complex duplications,
they are even copy number variant
between humans. We have a gene family
we call ‘‘Morpheus’’, which we published
in 2001. Some people have 20 copies,
some have 16 copies.
So, what are the functions of these
genes? Tough question! This is the genet-
icist’s worst nightmare: Mice don’t have
them, so you can’t knock them out. There
are multiple copies in humans, so would
be tough to genotype. They are too far
away from any flanking tagged SNP to
find any type of association. So there are a
whole series of black holes.
Gitschier: What has been the thing
about your research that had you the
most jazzed?
Eichler: I’m still jazzed!
Four or five years ago I made a
conscious decision to go back to my
roots—to go back to human disease. Up
to that point, I was focusing on human
duplications strictly from the perspective
of structural variation in humans and
variation among primates. So taking what
I learnt from David Nelson and Jim
Lupski, I’ve come full circle, because we
are now studying children with disease,
and we’re finding what we think are
causes—at least associations—now. But
we’re doing it from the perspective of
looking at the genomic architecture, as
opposed to linkage or association.
Both of those make me feel good—I
love the evolutionary history of the human
genome, and I’m completely unapologetic
that I am anthropocentric—that if I were
doing the same thing in Drosophilia,i t
would not interest me. But in humans—I
care how we tick! That we can walk
Image 1. Evan Eichler
(Image: Ron Wurzer/AP)
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liberating—the fact that there is no perfect
genome—that all of us are made up of
deletions and structural changes and copy
number variations.
It’s amazing that any of us are ‘‘normal’’.
And maybe none of us really are—and
that’s the beauty of it!
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